United Therapeutics | UTHR - Umlaufvermögen

Aktienkurs
568.58
Täglich Wechseln
-7.21 -1.25%
Monatlich
-2.06%
Jährlich
86.21%
Q2 Prognose
557.15




Umlaufvermögen Veränderung Datum
Amarin USD 626.02M 23.87M 2026-03
Ardelyx USD 381.87M 447K 2026-03
Baxter International USD 6.85B 25M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
BioCryst Pharmaceuticals USD 373.62M 30.72M 2026-03
Biogen USD 9.19B 216.3M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Esperion Therapeutics USD 459.46M 3.11M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Halozyme Therapeutics USD 1B 177.83M 2026-03
Insmed USD 1.61B 181.04M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
J&J USD 59.17B 3.55B 2026-03
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
Moderna USD 5.77B 774M 2026-03
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 42.82B 76M 2026-03
PTC Therapeutics USD 2.25B 19.94M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03